Submission of intimation of allotment of equity shares pursuant to conversion of warrants.

Astal Laboratories Ltd has allotted 14,70,000 equity shares of Rs. 10 face value each at Rs. 40 per share (including Rs. 30 premium) to 11 non-promoter investors. This follows the conversion of warrants that were originally allotted on 27th November 2024. The warrant holders paid the remaining 75% (Rs. 30 per warrant) to convert their holdings into equity shares. The company received Rs. 4.41 crore from this conversion. As a result, the paid-up equity capital increased from Rs. 42.28 crore to Rs. 43.69 crore, with total shares rising from 42.22 million to 43.69 million.